Trials / Recruiting
RecruitingNCT05704413
Digestive Biobank for Exploring Microbiota-host Interactions
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Constitution of a biobank of tissues, whole blood and plasma samples and stools to identify markers associated with treatment response, postoperative morbidity including neuro-cognitive and mood complications and prognosis of Inflammatory Bowel disease or colorectal cancer.
Detailed description
Inflammatory Bowel disease (Crohn, Ulcerative colitis) and colorectal cancer are frequent affections and the microbiota plays a major role in their physiopathology involving the immune system. In this setting, the interplay between gut microbiota and brain is still unexplored. To evaluate the interaction of the microbiota and the immune system with the host in these two chronic diseases, we aim to create a prospective biobank. A small amount of tissue will be taken during surgery. A whole blood, plasma and stoll samples will also be taken from the patient. All samples will be anonymized.
Conditions
Timeline
- Start date
- 2021-06-17
- Primary completion
- 2026-09-17
- Completion
- 2026-09-17
- First posted
- 2023-01-30
- Last updated
- 2023-01-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05704413. Inclusion in this directory is not an endorsement.